The WACC of Nattopharma ASA (NATTO.OL) is 6.5%.
Range | Selected | |
Cost of equity | 5.7% - 7.4% | 6.55% |
Tax rate | 10.9% - 30.8% | 20.85% |
Cost of debt | 5.0% - 5.0% | 5% |
WACC | 5.7% - 7.3% | 6.5% |
Category | Low | High |
Long-term bond rate | 3.1% | 3.6% |
Equity market risk premium | 4.7% | 5.7% |
Adjusted beta | 0.56 | 0.57 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.7% | 7.4% |
Tax rate | 10.9% | 30.8% |
Debt/Equity ratio | 0.02 | 0.02 |
Cost of debt | 5.0% | 5.0% |
After-tax WACC | 5.7% | 7.3% |
Selected WACC | 6.5% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
NATTO.OL | Nattopharma ASA | 0.02 | 1.22 | 1.2 |
BIE.MI | Bioera SpA | 12.98 | -0.02 | 0 |
ENV.MI | Enervit SpA | 0.15 | 0.11 | 0.09 |
MIR.WA | Miraculum SA | 0.55 | 0.39 | 0.27 |
MPH.WA | Master Pharm SA | 0.05 | 0.35 | 0.34 |
NICO.ST | Nicoccino Holding AB (publ) | 0.03 | -1.29 | -1.25 |
NNH.ST | New Nordic Healthbrands AB | 0.26 | 0.17 | 0.14 |
PAP.AT | Papoutsanis Industrial and Commercial of Consumer Goods SA | 0.37 | 0.48 | 0.36 |
PHR.WA | Pharmena SA | 0.19 | 0.38 | 0.32 |
VLG.L | Venture Life Group PLC | 0.42 | 0.21 | 0.15 |
Low | High | |
Unlevered beta | 0.15 | 0.29 |
Relevered beta | 0.34 | 0.36 |
Adjusted relevered beta | 0.56 | 0.57 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for NATTO.OL:
cost_of_equity (6.55%) = risk_free_rate (3.35%) + equity_risk_premium (5.20%) * adjusted_beta (0.56) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.